Actively Recruiting
Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants
Led by Karolinska Institutet · Updated on 2025-12-12
128
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
L
Linkoeping University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.
CONDITIONS
Official Title
Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 15 and 29.
- A score above the cut-off 1.75 on HSCL-25
- Has a refugee or migrant background
- Has a good and stable internet connection
- Has access to a computer, tablet or smartphone
- Is fluent in reading and writing Arabic
- Has the ability to dedicate time to take part in the intervention for 6-10 weeks.
You will not qualify if you...
- Is suffering from a severe mental illness, such as psychosis or severe depression.
- Is suffering from substance abuse
- Is undergoing a psychological treatment
- Has a high risk of suicide
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Karolinska Institutet
Stockholm, Sweden, 113 64
Actively Recruiting
Research Team
S
Shervin Shahnavaz, PhD
CONTACT
A
Anahita Geranmayeh, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here